Jenkins, DR.
Auckland, C.
Chadwick, C.
Dodgson, AR.
Enoch, DA.
Goldenberg, SD.
Hussain, A.
Martin, J.
Spooner, E.
Whalley, T.
Funding for this research was provided by:
Cepheid UK Limited
Article History
Received: 2 February 2024
Accepted: 9 April 2024
First Online: 26 April 2024
Declarations
:
: All authors received honoraria from Cepheid for attending the round table. David Jenkins reports receiving speaker fees from Cepheid and Pfizer, and advisory board fees from Shionogi.David Enoch reports receiving a travel grant from Becton Dickinson and advisory board fees from Napp. Simon Goldenberg reports receiving consulting fees from Astra Zeneca, Tillotts, and EnteroBiotix, speaker fees from Tillotts and holds stock in iFast Diagnostics Ltd. Jessica Martin reports receiving honoraria from Gilead, Shionogi, Tillotts and Pfizer. Terry Whalley reports receiving consulting fees from Cepheid.All other authors report no competing interests.